Tumor enhancement ratio with unenhanced imaging is an independent prognostic factor for patients with hepatocellular carcinoma after transarterial chemoembolization
Objective To investigative whether the odds tumor enhancement ratio (OTER) on cross-sectional imaging is a prognostic factor for hepatocellular carcinoma after transarterial chemoembolization (TACE). Methods This study involved 126 patients who underwent TACE from May 2015 to March 2019. The signal...
Guardado en:
Autores principales: | Xi-Yuan Yang, Jiang-Bei Deng, Tian-Zhi An, Shi Zhou, Jun-Xiang Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9e7207538f2746039881f8a97ea5d805 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
por: Baur J, et al.
Publicado: (2016) -
The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
por: Lei Chen, et al.
Publicado: (2021) -
Transarterial Chemoembolization Combined With Endoscopic Therapy Is Beneficial for Unresectable Hepatocellular Carcinoma With Esophagogastric Varices
por: Ziwen Tao, et al.
Publicado: (2021) -
Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study
por: Ouyang T, et al.
Publicado: (2021) -
Quantitative dual-energy CT for evaluating hepatocellular carcinoma after transarterial chemoembolization
por: Xiaofei Yue, et al.
Publicado: (2021)